Topical immunization strategies (Q37791415)

23 August 2017

Topical immunization strategies (English)

1 reference

23 August 2017

0 references

2

J Holmgren

1 reference

23 August 2017

C Czerkinsky

1

1 reference

23 August 2017

22 September 2010

1 reference

23 August 2017

1 reference

23 August 2017

3

1 reference

23 August 2017

6

1 reference

23 August 2017

545-555

1 reference

https://scigraph.springernature.com/pub.10.1038/mi.2010.55

23 August 2017

0 references

cites work

Let's go mucosal: communication on slippery ground

1 reference

https://api.crossref.org/works/10.1038%2FMI.2010.55

Developmental aspects of the mucosal immune system: role of external environment, mucosal microflora and milk

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2010.55

Mucosal immunity and vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2010.55

NALT- versus Peyer's-patch-mediated mucosal immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2010.55

Oral immunization: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2010.55

Epithelial M cells: differentiation and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2010.55

Intestinal villous M cells: an antigen entry site in the mucosal epithelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2010.55

Dendritic cells in intestinal homeostasis and disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2010.55

Anatomical basis of tolerance and immunity to intestinal antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2010.55

Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2010.55

Gastrointestinal dendritic cells play a role in immunity, tolerance, and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2010.55

Homing receptors and vascular addressins: cell adhesion molecules that direct lymphocyte traffic.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2010.55

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2010.55

Generation of gut-homing IgA-secreting B cells by intestinal dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2010.55

Intestinal dendritic cells increase T cell expression of alpha4beta7 integrin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2010.55

Selective imprinting of gut-homing T cells by Peyer's patch dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2010.55

Functional specialization of gut CD103+ dendritic cells in the regulation of tissue-selective T cell homing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2010.55

21 January 2018

Mucosal dendritic cells

1 reference

https://api.crossref.org/works/10.1038%2FMI.2010.55

CCL28 controls immunoglobulin (Ig)A plasma cell accumulation in the lactating mammary gland and IgA antibody transfer to the neonate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2010.55

Local and systemic immune responses to rectal administration of recombinant cholera toxin B subunit in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2010.55

Comparison of different routes of vaccination for eliciting antibody responses in the human stomach

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2010.55

Intestinal immune responses in humans. Oral cholera vaccination induces strong intestinal antibody responses and interferon-gamma production and evokes local immunological memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2010.55

Differential expression of tissue-specific adhesion molecules on human circulating antibody-forming cells after systemic, enteric, and nasal immunizations. A molecular basis for the compartmentalization of effector B cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2010.55

Nasal and vaginal vaccinations have differential effects on antibody responses in vaginal and cervical secretions in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2010.55

Immunological memory after immunization with oral cholera B subunit--whole-cell vaccine in Swedish volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2010.55

Sublingual vaccination with influenza virus protects mice against lethal viral infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2010.55

Sublingual immunization with nonreplicating antigens induces antibody-forming cells and cytotoxic T cells in the female genital tract mucosa and protects against genital papillomavirus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2010.55

CCR7-CCL19/CCL21-regulated dendritic cells are responsible for effectiveness of sublingual vaccination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2010.55

Identification of a novel chemokine (CCL28), which binds CCR10 (GPR2)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2010.55

A novel chemokine ligand for CCR10 and CCR3 expressed by epithelial cells in mucosal tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2010.55

CCR10 expression is a common feature of circulating and mucosal epithelial tissue IgA Ab-secreting cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2010.55

Cutting Edge: Langerin+ Dendritic Cells in the Mesenteric Lymph Node Set the Stage for Skin and Gut Immune System Cross-Talk

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2010.55

Delivery systems and adjuvants for oral vaccines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2010.55

Adjuvants modulating mucosal immune responses or directing systemic responses towards the mucosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2010.55

Mucosal immunisation: adjuvants and delivery systems.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2010.55

Status and future prospects of lipid-based particulate delivery systems as vaccine adjuvants and their combination with immunostimulators

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2010.55

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2010.55

Lipid-based cochleates: a promising formulation platform for oral and parenteral delivery of therapeutic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2010.55

Polymer-grafted starch microparticles for oral and nasal immunization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2010.55

Poly[di(carboxylatophenoxy)phosphazene] (PCPP) is a potent immunoadjuvant for an influenza vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2010.55

Overview of vaccines and vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2010.55

Recombinant proteins produced in insect cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2010.55

The production of hemagglutinin-based virus-like particles in plants: a rapid, efficient and safe response to pandemic influenza

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2010.55

Virus-like particles-universal molecular toolboxes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2010.55

The coming of age of virus-like particle vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2010.55

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2010.55

ADP-ribosylating bacterial enzymes for the targeted control of mucosal tolerance and immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2010.55

Cytokines as vaccine adjuvants: interleukin 1 and its synthetic peptide 163-171.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2010.55

Transient facial nerve paralysis (Bell's palsy) following intranasal delivery of a genetically detoxified mutant of Escherichia coli heat labile toxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2010.55

Tropical sprue in southern India

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2010.55

The pathology of malabsorption: current concepts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2010.55

Child undernutrition, tropical enteropathy, toilets, and handwashing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2010.55

Skin immunization made possible by cholera toxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2010.55

CD11c(high )dendritic cells are essential for activation of CD4+ T cells and generation of specific antibodies following mucosal immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2010.55

7 January 2021

Specific-antibody-secreting cells in the rectums and genital tracts of nonhuman primates following vaccination

1 reference

https://api.crossref.org/works/10.1038%2FMI.2010.55

7 January 2021

Local intravaginal vaccination of the female genital tract

1 reference

https://api.crossref.org/works/10.1038%2FMI.2010.55

7 January 2021

Induction of compartmentalized B-cell responses in human tonsils

1 reference

https://api.crossref.org/works/10.1038%2FMI.2010.55

7 January 2021

Differential kinetics and distribution of antibodies in serum and nasal and vaginal secretions after nasal and oral vaccination of humans

1 reference

https://api.crossref.org/works/10.1038%2FMI.2010.55

7 January 2021

Sublingual immunization induces broad-based systemic and mucosal immune responses in mice

1 reference

https://api.crossref.org/works/10.1038%2FMI.2010.55

7 January 2021

Sublingual immunization protects against Helicobacter pylori infection and induces T and B cell responses in the stomach

1 reference

https://api.crossref.org/works/10.1038%2FMI.2010.55

7 January 2021

Boosting of Secretory IgA Antibody Responses in Man by Parenteral Cholera Vaccination

1 reference

https://api.crossref.org/works/10.1038%2FMI.2010.55

7 January 2021

Water-soluble phosphazene polymers for parenteral and mucosal vaccine delivery

1 reference

https://api.crossref.org/works/10.1038%2FMI.2010.55

7 January 2021

Vaccines to prevent infections by oncoviruses

1 reference

https://api.crossref.org/works/10.1038%2FMI.2010.55

7 January 2021

Mucosal adjuvants and anti-infection and anti-immunopathology vaccines based on cholera toxin, cholera toxin B subunit and CpG DNA

1 reference

https://api.crossref.org/works/10.1038%2FMI.2010.55

7 January 2021

Nasal vaccination, Escherichia coli enterotoxin, and Bell's palsy

1 reference

https://api.crossref.org/works/10.1038%2FMI.2010.55

7 January 2021

Novel immunostimulatory agent based on CpG oligodeoxynucleotide linked to the nontoxic B subunit of cholera toxin

1 reference

https://api.crossref.org/works/10.1038%2FMI.2010.55

7 January 2021

https://api.crossref.org/works/10.1038%2FMI.2010.55

1 reference

7 January 2021

Identifiers

DOI

10.1038/MI.2010.55

1 reference

23 August 2017

1 reference

PubMed ID

20861833